Larson Financial Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.7K Sell
180
-18
-9% -$3.31K ﹤0.01% 1716
2026
Q1
$37.4K Buy
198
+86
+77% +$18.1K ﹤0.01% 1513
2025
Q4
$22.3K Buy
112
+27
+32% +$5.46K ﹤0.01% 1655
2025
Q3
$17.3K Buy
85
+60
+240% +$10.6K ﹤0.01% 1725
2025
Q2
$4.4K Sell
25
-72
-74% -$10.8K ﹤0.01% 2114
2025
Q1
$13K Buy
97
+90
+1,286% +$11.9K ﹤0.01% 1537
2024
Q4
$884 Sell
7
-1
-13% -$149 ﹤0.01% 2066
2024
Q3
$1.33K Buy
8
+7
+700% +$1.06K ﹤0.01% 1928
2024
Q2
$133 Hold
1
– – ﹤0.01% 2190
2024
Q1
$105 Hold
1
– – ﹤0.01% 1699
2023
Q4
$76 Buy
+1
New +$63 ﹤0.01% 1726

Other funds holding THC

Larson Financial Group's THC Position: Q2 2026 in Review

Larson Financial Group reduced its Tenet Healthcare (THC) stake by 9.1% in Q2 2026, selling an estimated $3.31K and leaving 180 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Larson Financial Group first reported a position in THC in Q4 2023 and has held it in 11 quarters since. The position peaked at $37.4K in Q1 2026. 682 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Larson Financial Group held 180 shares of Tenet Healthcare worth $33.7K as of Q2 2026.
  • Larson Financial Group sold 18 Tenet Healthcare shares in Q2 2026, an estimated $3.31K.
  • Tenet Healthcare made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1716 holding.
  • Larson Financial Group first reported a position in Tenet Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Larson Financial Group's Tenet Healthcare position peaked at $37.4K in Q1 2026.
  • 682 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.